Company news
Resonance Health Ltd news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Change in Substantial Holding
November 10, 2026
MRI Muscle Endpoint - Product Update
November 10, 2026
Alteration to Notice of Meeting
November 6, 2026
Cleansing Notice
November 6, 2026
Application for quotation of securities - RHT
November 6, 2026
TrialsWest East-Coast Expansion - Executive Appointment
November 3, 2026
Liver Fibrosis Device Webinar Presentation
October 27, 2026
Liver Fibrosis Device Webinar Presentation
October 27, 2026
Investor Presentation Liver Fibrosis Device & Capital Raise
October 26, 2026
Proposed issue of securities - RHT
October 26, 2026
$6.0 Million Placement Oversubscribed
October 26, 2026
Liver Fibrosis Device - EPoC Study Results
October 26, 2026
Trading Halt
October 22, 2026
Notice of Annual General Meeting/Proxy Form
October 20, 2026
Liver Fibrosis Device - Clinical Trial Results - Webinar
October 19, 2026
AGM Date & Director Nomination Closing Date
September 29, 2026
Change in Substantial Holding
September 24, 2026
Global Strategic Alliance & MSA with Image Analysis Group
September 16, 2026
Appendix 4G & Corporate Governance Statement
August 31, 2026
FY26 Full Year Results & Investor Webinar
August 27, 2026
FY26 Full Year Results & FY27 Guidance Investor Presentation
August 27, 2026
Appendix 4E, Full Year Statutory Accounts & Annual Report
August 27, 2026
FY26 Full Year Results Webinar
August 18, 2026
Cessation of Quarterly Reporting
August 11, 2026
Liver Fibrosis Device Progress & FY26 Portfolio Webinar
June 8, 2026
Profit Guidance Upgrade
May 5, 2026
Receipt of R&D Tax Incentive Refund
March 16, 2026
Half Year Results Presentation
February 26, 2026
Half Year Results
February 26, 2026
Half Year Report & Accounts
February 26, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 29, 2026
AGM Presentation
November 13, 2025
Investor Strategy Day Presentation
October 13, 2025
FY25 Full Year Results & FY26 Guidance Investor Presentation
August 29, 2025
Appendix 4E & Full Year Statutory Accounts
August 29, 2025
TrialsWest Expands with New Clinical Trial Site
July 8, 2025
Half Yearly Report and Accounts
February 27, 2025
Non-deal Investor Roadshow Presentation
December 1, 2024
Resonance Contracted by Major Global Pharma
November 18, 2024
Trading Halt
November 17, 2024
Full Year Results Presentation
August 29, 2024
Full Year Results
August 29, 2024
Appendix 4E & Annual Report to Shareholders
August 29, 2024
TrialsWest Expansion - New Trial Site
August 8, 2024
Completion of TrialsWest Acquisition
May 31, 2024
Investor Presentation - TrialsWest Acquisition
April 2, 2024
Acquisition of TrialsWest Group
April 2, 2024
Pause in Trading
March 28, 2024
Collaboration with Micron, Inc.
March 27, 2024
Half Yearly Report Results Announcement
February 28, 2024
Decks
The 5 newest of 44 decks. Every deck is listed under its year.
- Corporate Update (October 2026)
Corporate update · 31 slides · Oct 28, 2026
- Investor Presentation (October 2026)
Investor deck · 29 slides · Oct 27, 2026
- FY2026 Earnings Presentation
Earnings · 35 slides · Aug 28, 2026
- H1 FY2026 Earnings Presentation
Earnings · 16 slides · Feb 27, 2026
- Shareholder Meeting (November 2025)
Shareholder meeting · 13 slides · Nov 13, 2025